Pko Investment Management Joint Stock CO Regeneron Pharmaceuticals, Inc. Transaction History
Pko Investment Management Joint Stock CO
- $882 Billion
- Q1 2025
A detailed history of Pko Investment Management Joint Stock CO transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Pko Investment Management Joint Stock CO holds 15,300 shares of REGN stock, worth $9.23 Million. This represents 1.1% of its overall portfolio holdings.
Number of Shares
15,300
Previous 10,800
41.67%
Holding current value
$9.23 Million
Previous $7.69 Billion
26.13%
% of portfolio
1.1%
Previous 0.96%
Shares
13 transactions
Others Institutions Holding REGN
# of Institutions
1,484Shares Held
87.1MCall Options Held
1.53MPut Options Held
1.43M-
Vanguard Group Inc Valley Forge, PA9.29MShares$5.61 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.1 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$4.26 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.83MShares$2.92 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$2.86 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $64.7B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...